We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The investigational injection SI-6603 may decrease pain ...

The management of lumbar radicular pain has evolved considerably in recent years, with increasing emphasis on individualising treatment strategies to address both the peripheral and central components ...

The U.S. FDA’s Anesthetic and Analgesic Drug Products Advisory Committee will scrutinize Jan. 10 the safety and efficacy of Ferring Pharmaceuticals Inc.’s SI-6603 (condoliase), a chemonucleolytic drug ...

PLYMOUTH, Minn.--(BUSINESS WIRE)--SpineThera, Inc., a leading clinical-stage pharmaceutical company specializing in innovative injectable drugs, is thrilled to announce groundbreaking results from an ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals and its clinical development partner, Seikagaku Corporation (Seikagaku), today announced they will be presenting an analysis of data at the ...

Leg pain, cramps and lingering foot wounds are among the symptoms that may indicate peripheral artery disease, the narrowing or blockage of the vessels that supply blood to the legs. Getty Images ...

Eliem Therapeutics ELYM has completed dosing of the last patient in its Phase 2a trial of ETX-810 in patients with chronic lumbosacral radicular pain (LSRP). During the Phase 2a proof-of-concept trial ...